Literature DB >> 33733827

The potential application of dual-energy subtraction radiography for COVID-19 pneumonia imaging.

Brent van der Heyden1.   

Abstract

X-ray imaging plays a crucial role in the confirmation of COVID-19 pneumonia. Chest X-ray radiography and CT are two major imaging techniques that are currently adopted in the diagnosis of COVID-19 pneumonia. However, dual-energy subtraction radiography is hardly discussed as potential COVID-19 imaging application. More advanced X-ray radiography equipment often supports dual-energy subtraction X-ray radiography. Dual-energy subtraction radiography enables the calculation of pseudo-radiographs, in which bones are removed and only soft-tissues are highlighted. In this commentary, the author would like to draw the attention to the potential use of dual-energy subtraction X-ray radiography (i.e. soft-tissue pseudo-radiography) for the assessment and the longitudinal follow-up of COVID-19 pneumonia.

Entities:  

Mesh:

Year:  2021        PMID: 33733827      PMCID: PMC8010552          DOI: 10.1259/bjr.20201384

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


Commentary

Chest X-ray radiography imaging plays a crucial role in the confirmation of pneumonia in patients with severe respiratory symptoms caused by COVID-19.[1] X-ray radiography has already been suggested as first-line imaging modality of patients with suspected COVID-19 pneumonia in a pandemic scenario with a worldwide increasing number of inpatients.[2,3] Alternatively, institutes adopted CT imaging as main or complimentary diagnostic tool for the assessment and the evaluation of COVID-19 pneumonia over time.[4-7] Undoubtedly, CT imaging provides superior three-dimensional diagnostic information in contrast to planar X-ray radiography. Nevertheless, the CT imaging workflow requires more time, involves a much larger radiation dose,[8,9] and cannot be followed locally at the bedside. These are important aspects that should normally be considered in a pandemic scenario where health-care workers and hospitals work under constantly increased pressure. The author would like to draw attention to the potential use of dual-energy subtraction chest X-ray radiography in the assessment or evaluation of COVID-19 pneumonia. Dual-energy subtraction radiography is a well-established imaging technique available in several commercial devices that acquires two imaging exposures at different X-ray energies in a relatively short time-interval between the successive exposures (∼200 ms).[10,11] Dual-energy radiography is performed at one low X-ray energy spectrum (e.g. 70 kVp) and at one high X-ray energy spectrum (e.g. 130 kVp). Therefore, dual-energy subtraction radiography takes advantages of the more pronounced X-ray attenuation changes at lower X-ray energies in calcium-containing human tissues such as cortical bone. Applying dedicated weighted post-processing techniques on two X-ray exposures facilitates the calculation of two separate pseudo-radiographs representing the (i) soft-tissue content, and the (ii) bone content (Figure 1c–d).
Figure 1.

The low (a) and high (b) energy X-ray radiographs, and the post-processed pseudo-radiographs representing the soft-tissue (c) and the bone content (d) in the chest of a patient diagnosed with COVID-19 pneumonia. (Data set: coronacases_002.nii.gz from Jun et al[12])

The low (a) and high (b) energy X-ray radiographs, and the post-processed pseudo-radiographs representing the soft-tissue (c) and the bone content (d) in the chest of a patient diagnosed with COVID-19 pneumonia. (Data set: coronacases_002.nii.gz from Jun et al[12]) It should be noted that dual-energy subtraction radiography leads to an increased radiation dose compared to conventional radiography when the medical device is operating in dual-shot mode. However, the radiation dose of dual-energy subtraction X-ray radiography (∼0.2 mSv) is still substantially lower than the dose given by a chest CT scan (∼7.0 mSv).[9] Additionally, image artifacts could be introduced near the diaphragm or cardiac wall due to respiratory or cardiac motion within the 200 ms exposure timeframe.[10] Often, this effect is minimal and can be resolved by post-processing software. Publications on bone suppression X-ray chest radiography (i.e. soft-tissue pseudo-radiographs) have shown increased sensibility in other subtle imaging applications, such as the recognition of pulmonary nodules and interstitial lung diseases.[13-15] Therefore, it could also be relevant to validate the potential use of dual-energy subtraction X-ray imaging in the diagnosis of COVID-19 pneumonia. To the author’s best knowledge, public dual-energy radiography data sets of COVID-19 pneumonia are currently lacking, and for that reason, realistically simulated radiographs are presented in this commentary as example. The dual-energy X-ray chest radiographs are simulated from an open-access high-resolution CT data set of a patient diagnosed with COVID-19 pneumonia.[12] It is anticipated that the image quality of true pseudo-radiographs will outperform the quality of simulated radiographs due to computational restrictions. A detailed Monte Carlo simulation workflow is provided as Supplementary Material 1. Click here for additional data file. Figure 1(a–b) presents the 70 kVp and 130 kVp chest X-ray radiographs, and Figure 1(c–d) shows the soft-tissue and bone pseudo-radiographs obtained after dedicated post-processing and dual-energy subtraction. The author foresees that the lung volume after bone suppression (Figure 1c), and thus COVID-19 pneumonia, could be better visible in soft-tissue pseudo-radiographs than in conventional X-rays chest radiographs. Especially in early stage COVID-19 pneumonia, the dense ribs could possibly mask essential anatomical information which would have stayed unnoticed in conventional X-ray radiography (e.g. Figure 1c, green arrow). The application of dual-energy subtraction radiograph has been confirmed in literature to provide superior soft-tissue pseudo radiographs in several radiological applications.[13,14,16] Based on the available literature and the simulated imaging data presented in this commentary, it would be opportune to investigate the potential added value of soft-tissue pseudo-radiography in the diagnosis of COVID-19 pneumonia with prospective imaging trials.
  15 in total

1.  Clinical evaluation of pulmonary nodules with dual-exposure dual-energy subtraction chest radiography.

Authors:  Masahiko Uemura; Masao Miyagawa; Yoshifumi Yasuhara; Tadashi Murakami; Hirohiko Ikura; Kana Sakamoto; Hiroyuki Tagashira; Kenji Arakawa; Teruhito Mochizuki
Journal:  Radiat Med       Date:  2005-09

Review 2.  Dual energy subtraction: principles and clinical applications.

Authors:  Peter Vock; Zsolt Szucs-Farkas
Journal:  Eur J Radiol       Date:  2009-05-06       Impact factor: 3.528

Review 3.  Effective doses in radiology and diagnostic nuclear medicine: a catalog.

Authors:  Fred A Mettler; Walter Huda; Terry T Yoshizumi; Mahadevappa Mahesh
Journal:  Radiology       Date:  2008-07       Impact factor: 11.105

4.  Computed tomography of covid-19 pneumonia.

Authors:  Han Ma; Yaqin Zhang
Journal:  BMJ       Date:  2020-07-09

5.  Small lung cancers: improved detection by use of bone suppression imaging--comparison with dual-energy subtraction chest radiography.

Authors:  Feng Li; Roger Engelmann; Lorenzo L Pesce; Kunio Doi; Charles E Metz; Heber Macmahon
Journal:  Radiology       Date:  2011-09-23       Impact factor: 11.105

6.  The role of chest radiography in confirming covid-19 pneumonia.

Authors:  Joanne Cleverley; James Piper; Melvyn M Jones
Journal:  BMJ       Date:  2020-07-16

7.  Conventional chest radiography vs dual-energy computed radiography in the detection and characterization of pulmonary nodules.

Authors:  F Kelcz; F E Zink; W W Peppler; D G Kruger; D L Ergun; C A Mistretta
Journal:  AJR Am J Roentgenol       Date:  1994-02       Impact factor: 3.959

8.  Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT.

Authors:  Min Lang; Avik Som; Dexter P Mendoza; Efren J Flores; Nicholas Reid; Denston Carey; Matthew D Li; Alison Witkin; Josanna M Rodriguez-Lopez; Jo-Anne O Shepard; Brent P Little
Journal:  Lancet Infect Dis       Date:  2020-04-30       Impact factor: 25.071

Review 9.  COVID-19 pneumonia: A review of typical CT findings and differential diagnosis.

Authors:  C Hani; N H Trieu; I Saab; S Dangeard; S Bennani; G Chassagnon; M-P Revel
Journal:  Diagn Interv Imaging       Date:  2020-04-03       Impact factor: 4.026

10.  Variations in CT Utilization, Protocols, and Radiation Doses in COVID-19 Pneumonia: Results from 28 Countries in the IAEA Study.

Authors:  Mannudeep K Kalra; Jenia Vassileva; Fatemeh Homayounieh; Ola Holmberg; Rashid Al Umairi; Sallam Aly; Algidas Basevičius; Paulo Roberto Costa; Adham Darweesh; Vesna Gershan; Pilvi Ilves; Desislava Kostova-Lefterova; Simone Kodlulovich Renha; Iman Mohseni; Osvaldo Rampado; Natalia Rotaru; Issahaku Shirazu; Valentin Sinitsyn; Tajana Turk; Claire Van Ngoc Ty
Journal:  Radiology       Date:  2020-11-10       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.